|
2022 Conference Publication Establishing the radiopharmaceutical [11C]C-PiB as "ready-to-use" in humans at the CAIBarkhausen, C., Stimson, H. R., Najdovski, L. and Reutens, D. (2022). Establishing the radiopharmaceutical [11C]C-PiB as "ready-to-use" in humans at the CAI. Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 52nd ASM, Brisbane, QLD, Australia, 13 – 15 May 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.15763 |
